Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-00-000017
Filing Date
2000-01-12
Accepted
2000-01-12 00:00:00
Documents
1
Group Members
CADUCEUS CAPITAL II, L.P.CADUCEUS CAPITAL TRUSTFINSBURY WORLDWIDE PHARMACEUTICAL TRUSTORBIMED ADVISERS INC /CTORBIMED ADVISORS LLCWORLDWIDE HEALTH SCIENCES PORTFOLIO

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 17794
  Complete submission text file 0000947871-00-000017.txt   19875
Mailing Address 152 SECOND AVE WALTHAM MA 02451
Business Address 153 SECOND AVE WALTHAM MA 02451 781-290-58
GELTEX PHARMACEUTICALS INC (Subject) CIK: 0001001425 (see all company filings)

EIN.: 043136767 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45787 | Film No.: 505925
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)